Introduction: Lateral medullary syndrome (LMS) is a rare stroke and often results from thrombosis or emboli of the vertebral artery or posterior-inferior cerebellar artery. There is a wide range of clinical manifestations found in this syndrome and treatment is done usually as symptomatic. Case Presentation: We present the case of an Iranian 45-year-old man with a history of vertigo, ataxia, hiccup, and eye abnormalities lasting for three days in Mahshahr city, Khuzestan province, Iran. We followed the clinical outcomes including signs and symptoms, additional diagnostic tests, treatments, and possible complications over six months. The purpose of this study is to aid the better recognition of LMS patients and initiate further interventional research. Conclusions: Most of the neurological symptoms of LMS recovered or completely resolved after six months. The patient reported an occasional mild headache, reduced left side paresthesia and right side hypoesthesia. Ataxia and fall down on the left side considerably improved. The visual abnormalities were not observed in the eye and neurological examinations, but the patient did report mild dry eyes. Other clinical presentations, such as fine tremors in the right hand, left-sided dysmetria, dizziness, and earache, were completely resolved.
Introduction
Lateral medullary syndrome (LMS), also known as Wallenberg syndrome or posterior inferior cerebellar artery (PICA) syndrome, is a rare cerebrovascular accident, comprising 2.5% of the ischemic strokes (1) . Often, LMS is caused by thrombosis or emboli of the vertebral artery, and less commonly the occlusion of PICA, superior middle, or inferior medullary artery (2) . Other causes of this syndrome are hemorrhage, dissection of the vertebral artery, cavernous angioma, and tumors (2) . In this syndrome, the posterolateral part of the medulla oblongata in the brain stem is affected (3). This part receives arterial blood supply from PICA, and PICA is a branch of vertebral artery (4) .
A wide range of clinical manifestations is found in LMS patients, depending on the involved anatomic structure, including visual abnormalities, decreased pain and temperature sensations on the ipsilateral face and contralateral body, ipsilateral hemiparesis, vertigo, ataxia, nausea and vomiting, a nasal voice, dysphonia, hoarseness, weakness or palatal palsy in the side of the body where the lesion resides, the absence of taste sensation, decreased gag reflex and dysphasia, and slurred speech (5) . The visual or eye abnormalities in LMS include different types of nystagmus, gaze palsy, saccadic, ipsipulsion, diplopia, the absence of corneal reflex, and Horner's syndrome (6) . LMS is characterized by sensory deficits affecting the trunk and extremities on the opposite side of the infarction and sensory deficits affecting the face and cranial nervous on the same side of the infarction (3).
Dysphagia is a result of nucleus ambiguous involvement (7) . Damage to the spinothalamic tract is the reason for the loss of pain and temperature sensation in the opposite side of the body (8) . Infarction of the cerebellum or the inferior cerebellar peduncle causes ataxia (9) . In LMS, a damage to the spinal trigeminal nucleus causes the absence of pain on the ipsilateral side of the face, as well as the absence of corneal reflex (5) . Nystagmus and vertigo result from the involvement of the vestibular nuclei (6) . Damage to the hypothalamo-spinal fibers and the sympathetic nervous system gives rise to Horner's syndrome (4). Paliwal et al. (6) reported a 52-year-old male patient with LMS that presented with difficulty in swallowing, nasal reCopyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited gurgitation of liquids, altered nasal quality of voice, and rightward deviation of eyes and nystagmus. Over four weeks, the ipsipulsion improved spontaneously. Ibrahim et al. reported a 37-year-old male patient with persistent hiccup after lunch. The neurological examination revealed that horizontal nystagmus, bulbar palsy with dysphagia, and nasal phonation of voice. This researcher did not follow the patient to evaluate the recovered or deteriorated neurological deficit (10) .
There is no specific treatment for LMS; treatment is symptomatic (9) . The prognosis of LMS is dependent on early and exact diagnosis and good management of this syndrome; however, this syndrome is underdiagnosed (9) . With optimal diagnosis and treatment, the prognosis for recovery of LMS is favorable (1) . Therefore, the cognition and notice of atypical clinical manifestations, diagnostic tests, and treatment approaches of LMS improve the management of this condition. On the other hand, a few case reports have followed the outcomes and disabilities of LMS patients after discharge from the hospital. In this paper, we report the clinical presentation, treatment process, and outcomes of an LMS patient six months after discharge from the hospital, which is a strong point of the present study. The purpose of this study is to aid the better recognition and management of LMS as an unusual type of ischemic stroke. In addition, this report can be a basis for further interventional research on LMS.
Case Presentation
A 45-year-old man was admitted to the Emergency Room of Imam Mosa Kazem Hospital of Mahshahr city, Khuzestan province, Iran, on 3 October 2016. The patient presented with an acute headache, given a score of 9 out of 10 on a visual analog scale (VAS) of pain, diagnosed with vertigo, persistent hiccup, and left side paresthesia lasting for three days. He was a known case of ischemic heart disease (IHD), hypertension (HTN), and Percutaneous Trans Coronary Angioplasty (PTCA) for the past two years. In addition, he had undergone coronary artery bypass graft (CABG) two years ago. The patient was taking the following medications prior to admission: Amlodipine, Sertraline, Betahistine, Clopidogrel, Atorvastatin, Metoprolol, and Aspirin tablets. The patient had a family history of laryngeal cancer; his sister had died from laryngeal cancer seven years ago, and his father was diabetic, who had died one year ago (Table 1) .
After admission to the emergency room (ER) and consulting with a neurologist, vital signs were evaluated by the neurologist, including heart rate, respiratory rate, blood pressure, and temperature. Blood pressure was measured 
Family history
Father was diabetic.
His sister suffered from laryngeal cancer.
Laboratory findings (on admission)
Blood , respectively. These investigated instruments were calibrated before use in this study. Subsequently, the patient was recommended to have complete bed rest and transferred to the Intensive Care Unit (ICU). The patient was hospitalized for one week in the ICU. During the ICU stay, the patient was conscious and left the bed after two days. He complained of an earache and dizziness when walking after complete bed rest.
Investigations
The laboratory tests were done on admission to ER according to physician order, which included BS, BUN, Cr, Na, K, CBC, PT, PTT, INR, Troponin I, Lactic Dehydrogenase (LDH), Liver Function Test (LFT), Creatine Phosphokinase (CPK), T3, T4, and Thyroid Stimulating Hormone (TSH). Some laboratory tests, including Triglycerides (TG), Cholesterol (Chol), Low-Density Lipoprotein cholesterol (LDL), High-Density Lipoprotein cholesterol (HDL), and urinalysis were done during ICU stay. In addition, some laboratory tests such as FBS, BUN, Cr, Na, K, CPK, LDH, CBC, PT, PTT, and INR were performed daily. Other lab tests were performed as needed, according to physician order. All lab tests were normal. The laboratory tests were done at the laboratory unit of Imam Musa Kazem Hospital, with devices and instruments including Sysmex (KXZIN), Mindray (BC-3000 Plus), ICUBio (imagic-M7), DIRUi CS-300-B, and Caretium. The instruments were calibrated before blood and urine sample analyzing.
On admission, electrocardiography (ECG) Bionet 2000, electroencephalography (EEG) Bionet 2000, chest x-ray, and brain Computed Tomography (CT) scan were performed. The instruments were calibrated before use. The ECG showed a normal sinus rhythm; EEG and brain CT were normal. The color Doppler sonography of carotid and vertebral artery, Transcranial Doppler Test (TCD), brain magnetic resonance imaging (MRI), and magnetic resonance angiography (MRA) were performed on days 1, 2, 3, and four after admission to the ICU, respectively. The physician referred the patient to an equipped medical center for Computed Tomography Angiography (CTA) after hospital discharge.
The findings of color Doppler sonography of both sides of the carotid and vertebral arteries revealed the presence of a partially calcified atheromatous plaque measured 7.7 × 1.3 mm seen in the posterior wall of the right carotid bulb, and another similar plaque measured 9.6 × 1.8 mm in the posterior wall of the proximal Right Internal Carotid Artery (RICA), which did not cause a significant luminal narrowing (20 -30%). In addition, a small partially calcified plaque measuring 9.6 × 1.9 mm was seen in the posterior wall of the proximal left Internal Carotid Artery (LICA) without significant luminal narrowing (~20%); both sides of the vertebral arteries showed no sign of hypoplasia or atheromatous plaque and normal flow direction without any sign of flow reversal or significant narrowing ( Figure  1 ).
TCD is a diagnostic test for CVA to evaluate blood flow velocity in blood vessels. Figure 2 shows the mean blood flow velocity in brain vessels. The figure reveals the obstruction of brain vessels due to the reduced mean blood flow values, decreased blood flow in Right Vertebral Artery (RVA) (mean flow = 24.6 cm/s, normal = 38), and mildly increased Intra Cranial Pressure (ICP) according to increasing pulsatility index (PI), which its normal value is 0.5 -1.9 ( Figure 2 ).
Brain computed tomography showed no acute infarct or hematoma, but brain MRI showed a few flair hyperintense foci in the cerebellar white matter, suggesting that there were small vessel ischemic changes (Figure 3 ). Brain MRA without contrast revealed no sign of significant stenosis or vascular malformation. Therefore, the cerebrovascular event was diagnosed as LMS with clinical features, with a pathognomonic finding of LMS in the brain MRI.
Imam Mosa Kazem Hospital is affiliated to the treatment management of Khuzestan social security organization that is a governmental organization. The employed instruments were calibrated before use in this study. Demographic and specific data related to disease were asked from the patient or his family, and other data were extracted from the patient's record or obtained from physical and neurological exams.
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Treatment
For the management of LMS, antiplatelet drugs (Aspirin, Clopidogrel), an anticoagulant drug (Heparin continual infusion for 24 hours), proton pump inhibitors (Pantoprazole), a β 1 -blocker agent (Metoprolol), and statins (Atorvastatin) were administered to the patient by a neurologist. After three days, the patient's blood pressure increased and antihypertensive drugs (Amlodipine, Losartan) initiated. Clopidogrel and Heparin discontinued and Warfarin started. In addition, Ketorolac, Betahistine, and Novafen were provided to the patient for the treatment of a headache, earache, and dizziness. The administration schedule of medications on admission to ICU was as follows:
1. Tab (tablet) ASA 80 mg Per Oral (PO) daily 2. Tab Clopidogrel 75 mg PO daily 3. Tab Atorvastatin 20 mg PO every night (Qhs) 4. Ampule (Amp) Heparin 5000 Unit Sub Cutaneous (SC) twice a day (BID) 5. Amp Pantoprazole 40 mg Intra Venous (IV) daily After two days of admission to the ICU, according to clinical manifestations, laboratory tests, and diagnostic investigations, the physician started continuous intravenous heparin 1000 U/h for 24 h. Three days after admission, the physician discontinued Tab Clopidogrel and continuous intravenous heparin, and initiated Amlodipine 5 mg PO daily, Tab Losartan 25 mg PO three times daily (TID), Tab Warfarin 5 mg PO daily, and Amp Ketorolac 30 mg IV stat injected. After five days in ICU, Tab Novafen 20 mg PO TID, Tab Betahistine 8 mg PO BID, and Tab Nortriptyline 25 mg PO were administered daily.
Follow-up
We followed the clinical outcomes of the patient six months after discharge through telephone and appointments. In addition, the researcher asked a neurologist to visit the patient and exam physical and neurological Mostly, the patient expressed signs and symptoms of recovery. For example, he reported an occasional mild headache versus an acute headache that had occurred six months ago, and the left side paresthesia and right side hypoesthesia were limited to the right leg and foot sole after six months. Ataxia and fall down on the left side were considerably improved and were limited to higher altitudes. The eye and visual abnormalities were not observed in the eye and neurological examinations, but the patient reported mild dry eyes. Other clinical presentations, such as fine tremors in the right hand, left-sided dysmetria, dizziness, and earache, were completely resolved. Table 2 shows the comparison between the symptoms in our study and other similar research.
Discussion
LMS is a type of rare ischemic stroke, which is often caused by thrombosis or embolism in the heart or great vessels (9) . The severity of clinical manifestations and emergency intervention and monitoring will be dependent on the cause and size of the affected area in the brainstem (10) . In severe events of LMS, patients have developed respiratory failure requiring intubation (11, 12, 14) ; for example, Tanaka et al. (11) and Sivakumar et al. (14) reported LMS patients with central hypoventilation as a complication of LMS requiring intubation and mechanical ventilation.
In previous studies, different types of visual abnormalities have been discussed, such as Horner's syndrome, diplopia, saccadic, gaze palsy, ipsipulsion, and nystagmus among LMS patients (5, 6, 15) . Tyagi et al. reported 71% and 54% of PICA infarcts resulting in ataxia-and gaze-evoked nystagmus, respectively (5). In our case, the patient had mild ptosis on the left eyelid, anisocoria, pupil reactivity to light, and left side Horner's syndrome.
A different severity of dysphagia may be seen in 51 -94% of LMS patients (10) . Some LMS patients experience mild dysphagia and recover in 1 -2 months after stroke; some experience severe dysphagia and need enteral nutrition for several months or years following the stroke (7). Kim et al. demonstrated dysphagia might be an indicator of poor outcome in acute LMS (16). Nakano et al. reported a 67-year-old man with dizziness, dysarthria, and dysphagia as the initial sign and symptoms of LMS. Then, nine days after admission, he presented with asymptomatic hyponatremia and he was diagnosed with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) (13) . In our study, the patient had partial dysphagia and could feed orally. The clinical presentations or laboratory data of hyponatremia and SIADH were not seen.
Hiccup is another symptom of LMS that sometimes is Iran Red Crescent Med J. 2018; 20(12):e63064. 5 (17); Ibrahim et al. described a case report on hiccup in LMS (10). Our patient also had persistent hiccup lasting for three days. Ataxia and balance impairment are present in almost all patients with LMS and sometimes persist for years even after recovery of other symptoms (17) . Ataxia may affect the gait pattern and daily activities of patients with LMS, resulting in a high risk of falling down (18) . In our study, the patient suffered from ataxia and fall down on the left side during admission to the hospital. After six months, this symptom restricted to when climbing and hiking mountains.
A strength of this study was good cooperation of the patient for answering to telephone and appointment questions in the ICU and after discharge from the hospital. In addition, the use of reliable, updated references about LMS that is an uncommon CVA was another strength of this paper.
A limitation of this study was the patient that lived in another city of Khuzestan province. However, the good cooperation of the patient and his family for telephone and appointment conversations minimized undesirable effects of this factor.
Conclusion
The outcome of LMS depends on the size and region of the lesion in the brainstem. The signs and symptoms of LMS can be reduced with treatment, but patients' recovery may take weeks or months following treatment. Other patients may be left with significant neurological disabilities for many years. We followed the clinical outcomes of a patient with LMS over six months after discharge. We found that over time, the patient has shown slow, but important progress in all neurological signs and symptoms of LMS.
Footnotes
Authors' Contribution: Sakine Mazaherpur, Avid Rokni, Ehsan Bastani Far, and Alireza Abdi contributed to conceptualization, data curation, investigation, project administration, supervision, and writing of the original draft.
Conflict of Interests:
No competing interests were disclosed.
Funding/Support:
The authors declare that there were no grants involved in supporting this work.
Informed Consent: Written informed consent was obtained from the patient regarding the publication of the patient's details and associated images.
